Exploring Three High Growth Tech Stocks In Asia

Amidst a backdrop of mixed global economic indicators, Asian markets have shown resilience, with China's stock indices recording gains and Japan's markets experiencing modest increases despite political uncertainties. In this environment, identifying high growth tech stocks in Asia requires careful consideration of factors such as innovation potential and adaptability to evolving market conditions.

Advertisement

Top 10 High Growth Tech Companies In Asia

NameRevenue GrowthEarnings GrowthGrowth Rating
Suzhou TFC Optical Communication30.23%29.66%★★★★★★
Gold Circuit Electronics20.76%25.89%★★★★★★
Shanghai Huace Navigation Technology24.51%23.48%★★★★★★
Range Intelligent Computing Technology Group27.31%28.63%★★★★★★
Shengyi Electronics26.23%37.40%★★★★★★
eWeLLLtd24.95%24.40%★★★★★★
PharmaResearch27.20%30.47%★★★★★★
Global Security Experts20.56%28.04%★★★★★★
CARsgen Therapeutics Holdings81.53%96.08%★★★★★★
JNTC55.45%94.52%★★★★★★

Click here to see the full list of 479 stocks from our Asian High Growth Tech and AI Stocks screener.

We're going to check out a few of the best picks from our screener tool.

Akeso (SEHK:9926)

Simply Wall St Growth Rating: ★★★★★★

Overview: Akeso, Inc. is a biopharmaceutical company focused on the global research, development, manufacture, and commercialization of antibody drugs with a market capitalization of HK$128.71 billion.

Operations: The company generates revenue primarily from the research, development, production, and sale of biopharmaceutical products, amounting to CN¥2.12 billion.

Akeso, Inc. is setting benchmarks in the biopharmaceutical sector with its innovative approach to cancer treatment, particularly through its recent advancements in bispecific antibodies and antibody-drug conjugates (ADCs). The company's R&D commitment is underscored by a robust pipeline of over 50 innovative assets, with significant investments that align well with industry demands for next-generation therapies. Notably, Akeso has achieved compelling clinical outcomes; for instance, their PD-1/VEGF bispecific antibody ivonescimab showed a median progression-free survival (mPFS) that significantly outperformed competitors in recent trials. With revenue growth forecasted at 32% annually and earnings expected to surge by approximately 41.6% per year, Akeso is strategically positioned to meet the growing global need for effective cancer treatments while enhancing its market presence aggressively.

SEHK:9926 Earnings and Revenue Growth as at Jul 2025
SEHK:9926 Earnings and Revenue Growth as at Jul 2025

Tsinghua Tongfang (SHSE:600100)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Tsinghua Tongfang Co., Ltd. operates in digital information, civil nuclear technology, energy conservation and environmental protection, and technology and finance sectors with a market cap of approximately CN¥24.96 billion.

Operations: The company generates revenue through its involvement in digital information, civil nuclear technology, energy conservation and environmental protection, and technology and finance sectors. Its market cap is approximately CN¥24.96 billion.

Tsinghua Tongfang is navigating the competitive landscape of Asia's tech sector with a focus on innovation and market adaptation. Despite a challenging quarter, with revenue dropping to CNY 2.02 billion from CNY 2.93 billion year-over-year and a widening net loss of CNY 287.6 million, the company's commitment to research and development remains unwavering. This dedication is evident in their strategic investments in emerging technologies, which could bolster future performance as evidenced by an impressive forecasted annual earnings growth of 93.8%. With recent corporate activities including an earnings call and annual general meeting, Tsinghua Tongfang is actively engaging with stakeholders to refine strategies and enhance its market position in high-growth tech sectors across Asia.

SHSE:600100 Earnings and Revenue Growth as at Jul 2025
SHSE:600100 Earnings and Revenue Growth as at Jul 2025

Servyou Software Group (SHSE:603171)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Servyou Software Group Co., Ltd. operates in China, offering financial and tax information services, with a market cap of CN¥19.54 billion.

Operations: The company focuses on providing financial and tax information services across China. It generates revenue primarily through its software solutions tailored for tax compliance and financial management.

Servyou Software Group is distinguishing itself in the high-growth tech sector in Asia, showcasing a robust annual revenue increase of 19.5% and an even more impressive earnings growth at 46.9%. This trajectory is supported by strategic R&D investments, which have amounted to significant yearly expenditures, aligning with industry demands for constant innovation and adaptation. The firm's recent financials reveal a Q1 revenue jump to CNY 448.74 million from CNY 362.7 million year-over-year, although net income slightly dipped to CNY 24.75 million from CNY 32.78 million, reflecting ongoing reinvestment into business capabilities and market expansion efforts. With these dynamics at play, Servyou is poised to maintain its competitive edge by leveraging technological advancements and expanding its market footprint.

SHSE:603171 Revenue and Expenses Breakdown as at Jul 2025
SHSE:603171 Revenue and Expenses Breakdown as at Jul 2025

Taking Advantage

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SHSE:603171

Servyou Software Group

Provides financial and tax information services in China.

High growth potential with excellent balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.671.8% undervalued
21 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.234.8% undervalued
50 users have followed this narrative
1 users have commented on this narrative
17 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2687.2% undervalued
33 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3412.8% undervalued
5 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

FA
ORGABIO logo
FA_Trader on Orgabio Holdings Berhad ·

Orgabio: A niche beverage manufacturer that is starting to show stronger scale, improving margins, and clearer earnings traction

Fair Value:RM 0.4839.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TH
LMT logo
TheBestInvestor on Lockheed Martin ·

Orbit + Aero + Defense

Fair Value:US$673.889.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
JI
BFBIO logo
jibran5237 on BF Biosciences ·

BFBIO is a long-duration growth platform

Fair Value:PK₨554.0472.2% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3954.1% overvalued
49 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3130.0% undervalued
1363 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.2k% overvalued
38 users have followed this narrative
11 users have commented on this narrative
32 users have liked this narrative